Tirzepatide Dosage: The Ladder, and the Units Trap

There are two separate questions hiding inside "tirzepatide dosage," and almost every page answers only the first.

The first is the schedule — how much, how often, and how it steps up. For the approved products that is not a secret or a matter of opinion. It is printed in FDA labeling, the titration is deliberately slow, and your prescriber sets it.

The second is the arithmetic, and it is where people actually get hurt. A dose is written in milligrams. An insulin syringe is marked in units. Those are not the same thing, they do not convert without a third number, and that third number — the concentration of your particular vial — is different from someone else's. Getting this wrong is not a small error; it scales the entire dose.

This page covers both, and is explicit that the second one is the reason it exists.

The Approved Schedule, and Why It Steps

The approved tirzepatide products — Mounjaro for type 2 diabetes and Zepbound for weight management, the same molecule under two labels — come as pre-filled pens at fixed strengths, and the labeled approach is a slow titration: start low, hold for several weeks, step up only if tolerated, with a defined maximum. Both products follow that shape, and the ladder below is the one their labels use.

The slowness is not caution theater. Gastrointestinal side effects are the dose-limiting problem with this drug class, and the titration exists to let tolerance develop. The trials that established the drug's efficacy — SURMOUNT-1 in obesity¹, the head-to-head SURPASS-2 against semaglutide², and the later diabetes-prevention work³ — all ran a titration rather than starting at the top. The results people quote came from the schedule, not from skipping it.

Two things follow that are worth stating plainly. Faster is not better: the higher dose did not produce its result by being reached sooner. And the maximum is a maximum, not a target — a substantial share of trial participants got their result below the top dose.

Your specific schedule is a clinical decision. What this page can tell you is what the numbers mean once you have them.

The Units Trap — Where the Real Risk Is

The approved pens hide this problem entirely: they are supplied ready to inject, at a fixed dose, and nothing is calculated. Compounded tirzepatide, bought through telehealth, usually does not work that way. It arrives as a vial with a milligram content, and you draw from it with a syringe marked in units.

Here is the relationship, and it is the whole article:

Concentration = vial strength ÷ liquid volume. A 30 mg vial in 1.5 mL is 20 mg/mL. On a U-100 insulin syringe, 100 units span 1 mL — always, for every U-100 syringe. So at 20 mg/mL, each unit mark carries 0.2 mg.

Now the part that catches people. Take that same 30 mg and put it in 3 mL instead: the concentration is 10 mg/mL, and each unit mark now carries 0.1 mg. Same vial, same drug, same syringe — and every unit mark is worth half as much. A schedule that says "draw to 12 units" is meaningless without knowing which of those vials you have.

That is why a dose written in units, copied from a forum or a friend, is not information. It is a number that was correct for somebody else's vial.

Our tirzepatide dosage calculator does this conversion from a dose you already have plus your vial's concentration. If you are mixing from a lyophilized powder, the water volume is the decision that sets the concentration in the first place — that is the tirzepatide reconstitution calculator, and the underlying relationship on its own is in the insulin syringe units converter.

Why the Same "5 mg" Is Not the Same Injection

Worth spelling out because it defeats a lot of otherwise careful people.

If two providers both sell "5 mg per week" and one supplies a 40 mg/mL vial while the other supplies a 10 mg/mL vial, the injection volumes differ fourfold. Both are 5 mg. Both are correct. The mark you draw to is completely different.

This is also why a misread mark costs different amounts on different vials. On a concentrated vial, one unit off the mark is a larger absolute error in milligrams than the same misread on a dilute one. Concentration decides how much a mistake costs, which is a good reason to understand it before it matters.

The general version of this arithmetic, across compounds, is in how to reconstitute peptides and how to inject peptides.

What the Titration Is Actually Managing

Worth naming the thing the schedule exists to control, because understanding it makes the schedule feel less arbitrary.

Gastrointestinal effects — nausea, vomiting, diarrhea, constipation — are the dose-limiting problem for this whole drug class. They cluster during escalation and generally ease as tolerance develops, which is precisely why the labeled approach holds each step for several weeks before the next.

Two practical consequences. Slowing down is the standard response to poor tolerance, and it is a conversation with your prescriber rather than a reason to abandon the drug. And the schedule is not a race: the pivotal trials ran the titration, so the results people quote are results of the schedule¹³. Arriving at the top dose sooner does not reproduce them faster.

The Questions the Schedule Does Not Answer

Three things come up constantly and none of them is a dosing-chart question.

A missed dose is a labeling question with a specific answer for each approved product, and it depends on how long since the missed dose and how close the next one is. Look it up for your specific product or ask the prescriber — this is not a place for a general rule.

Stopping is its own decision with its own consequences, including what happens to the weight, and it belongs in the same conversation as starting.

Maintenance — what dose holds a result rather than produces one — is a genuinely open question the trials were not designed to answer, which is the honest basis for the low-dose discussion in microdosing tirzepatide.

What Compounded Vials Actually Look Like on the Market

The concentration question is not hypothetical, and provider pages frequently make it hard to answer.

RxPepsDirect prices by the vial rather than the month — tirzepatide with B12 "From $45/12mg" and a B6/glycine version "From $225/60mg" — and never states how long a vial lasts, with a $39 visit fee and $15 shipping on every order. A vial price with a milligram figure and no schedule leaves the arithmetic entirely to you.

Others price the month but not the milligrams. SkinnyRx publishes four terms per product, with injectable tirzepatide at $399 monthly down to $299 on twelve months — clear on cost, and the dose question still belongs to the consultation. Care Bare Rx names injectable and oral tirzepatide as confirmed products and publishes a price for neither.

Note also that several sellers combine tirzepatide with B12 or with B6 and glycine. A combination vial is not the same product the trials studied, and its concentration figure describes the blend. Boards: best tirzepatide providers and cheapest tirzepatide online, with figures in the price transparency index.

The Legal Position Is Not Static

Compounded tirzepatide's regulatory standing has changed more than once, and it is not the same question as whether the molecule works. See is compounded semaglutide or tirzepatide still legal and the peptide FDA status tracker, which checks each compound against the primary record rather than against seller descriptions.

Bottom Line

The schedule is the easy half. Approved tirzepatide titrates slowly from a low starting dose to a defined maximum, the slowness exists because gastrointestinal effects are dose-limiting, and the trial results everyone quotes were produced by that schedule rather than in spite of it¹²³. The maximum is a ceiling, not a goal.

The hard half is arithmetic, and it only appears when you leave the approved pens. Milligrams are the dose; units are a distance on a syringe barrel; concentration is the only thing that connects them. A 30 mg vial in 1.5 mL gives 0.2 mg per unit mark. The same vial in 3 mL gives 0.1 mg. Any dose expressed in units, from anyone, is unusable without knowing which vial produced it.

If you take one thing away: never copy a unit number. Get the dose in milligrams from the person prescribing it, read the concentration off your own vial, and do the conversion yourself — the tirzepatide dosage calculator exists for exactly that, and every field starts blank because it converts your numbers rather than proposing any.

This page is educational and not medical advice. Dosing decisions belong with a licensed clinician who knows your history.